{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:23Z","timestamp":1741238663033,"version":"3.38.0"},"reference-count":6,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1684\/ejd.2019.3548","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:28:50Z","timestamp":1696865330000},"page":"334-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Erythema multiforme-like hypersensitivity reaction to infliximab: an atypical and refractory case"],"prefix":"10.1684","volume":"29","author":[{"given":"Takuya","family":"Mizukami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Miyazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Katsurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"3548_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1600-0560.2012.01894.x","volume":"39","author":"EB Hawryluk","year":"2012","unstructured":"Hawryluk EB, Linskey KR, Duncan LM, Nazarian RM. Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists. J Cutan Pathol 2012; 39: 481\u201392.","journal-title":"J Cutan Pathol"},{"key":"3548_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M15-0729","volume":"164","author":"I Cleynen","year":"2016","unstructured":"Cleynen I, Van Moerkercke W, Billiet T, et al. Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study. Ann Intern Med 2016; 164: 10\u201322.","journal-title":"Ann Intern Med"},{"key":"3548_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jaad.2008.10.060","volume":"61","author":"AE Moustou","year":"2009","unstructured":"Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol 2009; 61: 486\u2013504.","journal-title":"J Am Acad Dermatol"},{"key":"3548_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cgh.2010.07.022","volume":"8","author":"JF Rahier","year":"2010","unstructured":"Rahier JF, Buche S, Peyrin-Biroulet L, et al. Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol 2010; 8: 1048\u201355.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3548_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1744-9987.12113","volume":"17","author":"M Sakanoue","year":"2013","unstructured":"Sakanoue M, Takeda K, Kawai K, Kanekura T. Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy. Ther Apher Dial 2013; 17: 477\u201383.","journal-title":"Ther Apher Dial"},{"key":"3548_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/1346-8138.12789","volume":"2","author":"A Arimura","year":"2015","unstructured":"Arimura A, Hatanaka M, Katsue H, Matsushita S, Kanekura T. Granulocyte and monocyte adsorption apheresis for paradoxical reaction to infliximab. J Dermatol 2015; 2: 438\u20139.","journal-title":"J Dermatol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2019.3548\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:21:50Z","timestamp":1741191710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3548"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2019.3548","relation":{},"ISSN":["1952-4013"],"issn-type":[{"type":"electronic","value":"1952-4013"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"25 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Disclosure. Financial support: none. Conflicts of interest: none.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}